{"id":"https://genegraph.clinicalgenome.org/r/0bb70629-5021-43d7-bf4b-8988e33bad44v1.0","type":"EvidenceStrengthAssertion","dc:description":"Primary Ciliary Dyskinesia (PCD) is a genetically heterogeneous group of disorders, usually beginning in early childhood, characterized by chronic cough, recurrent infections of the upper and lower respiratory tract, randomization of left/right body asymmetry, and subfertility (PMID: 32943623). A subset of PCD cases have complex congenital heart defects (PMID: 17515466). The PCD phenotype results from structural and/or functional abnormalities of motile cilia and flagella. The axonemes of most motile cilia have a 9+2 microtubule structure with nine peripheral doublet microtubules surrounding a central pair apparatus (CPA). Sperm flagella also have a 9+2 axonemal structure that is required for sperm motility. Motile 9+0 cilia lack a central pair and are found in the embryonic node where they play a role in establishing leftâ€“right asymmetry. The CPA is a complex structure that regulates ciliary motility and waveform (PMID: 35578022). The CPA comprises at least ten protein complexes, or projections, that associate with two central microtubules (PMID: 35578023). The Cilia-and Flagella-Associated Protein 46 (CFAP46) is a subunit of one of these projections, the C1d projection.\n\n*CFAP46* was first reported in relation to a PCD patient by Wohlgemuth et al. in 2024 (PMID: 39362668). Wohlgemuth et al. report a proband with biallelic *CFAP46* likely pathogenic variations and chronic respiratory symptoms including chronic rhinitis and sinusitis, bronchiectasis, and chronic ear and hearing symptoms. This patient had a normal nasal nitric oxide production rate (235.6 nL/min), normal ciliary beating by high-speed video microscopy, and normal ciliary ultrastructure by transmission electron microscopy (TEM). This patient did not present with situs abnormalities, which are typically associated with dysfunction of motile cilia of the embryonic node. Nodal cilia lack a central pair apparatus, so patients with *CFAP46*-PCD would not be expected to develop the laterality defects often associated with PCD (PMID: 33279404).\n\nGenetic evidence from a single proband carrying compound heterozygous *CFAP46* variations from one publication was evaluated in this curation (PMID: 39362668). Two unique variants were scored: NM_001200049.3(CFAP46):c.19C>T(p.Gln7Ter), a nonsense mutation, and c.7286-2A>G(p.(Glu2429Gly_Met2430insfsTer9), a splice site variation shown by cDNA sequence analysis to lead to the activation of a cryptic splice site, causing a frameshift and premature stop. Of note, one additional unpublished PCD patient with heterozygous likely pathogenic *CFAP46** variations and a central pair sheath defect in TEM studies was discussed by the Motile Ciliopathy GCEP but not included in this curation (M. Lejendre, personal communication, May 30, 2024).\n\nPer criteria outlined by the ClinGen Lumping and Splitting Working Group we are asserting that *CFAP46*-Related Primary Ciliary Dyskinesia (MONDO:1010146) is a single autosomal recessive disease entity caused by inherited biallelic mutation in the *CFAP46 gene*. Please note that there remains a need for publication of additional probands to add support to this gene-disease association and to better establish the spectrum of phenotypes associated with *CFAP46*-related disease.\n\nThe gene-disease association between *CFAP46* and PCD is supported by gene expression data that show *CFAP46* expression in multiciliated tissues. GTEx RNA-seq expression studies in reference human tissues show strong expression of *CFAP46* in lung, testis, brain, and Fallopian tube (PMID: 23715323). This pattern is consistent with CFAP46 as a subunit of the C1d projection in the CPA of motile cilia and flagella (sperm). CFAP46 together with CFAP54, CFAP74, and CFAP221 are among the subunits that form the C1d projection. Coimmunoprecipitation studies using *Chlamydomonas reinhardtii* axonemal extracts confirm the interaction of these four proteins (PMID: 20421426). The analysis of high-resolution structures of the *C. reinhardtii* central apparatus by cryo-electron microscopy confirms a physical interaction between FAP46 and FAP54 within the C1d projection (PMID: 35578022). Immunofluorescence microscopy analyses of respiratory epithelial cells show that CFAP46 localizes along the entire ciliary axoneme in healthy individuals but is lost in the respiratory cells of a *CFAP46*-PCD patient (PMID:39362668). This loss suggests the disruption of the C1d projection. *In vitro* ciliary transport assays analyzing the ciliary transport of fluorescent nanoparticles on cultured respiratory epithelium from this *CFAP46*-PCD patient and healthy controls show that *in vitro* ciliary transport is impaired in the patient (PMID:39362668).\n\nOne non-human model-organism was used to support the gene-disease relationship between *CFAP46* and PCD. *Chlamydomonas reinhardtii* cells carrying a null mutant for FAP46 have full length flagella but lack the C1d projection, resulting in impaired motility (PMID: 22573824). Rescue of the null mutant cells with wild-type *FAP46* restores cell motility and normal flagellar movement. This same study shows that loss of FAP46 in Chlamydomonas results in a significant reduction in microtubule-sliding velocity, providing insight into the possible mechanism behind CFAP46 flagellar/ciliary motility defects (PMID: 22573824).\n\nIn summary, while this curation has technically scored as a Moderate classification, the Motile Ciliopathy GCEP has decided that in light of only one proband providing genetic evidence and this proband carrying possibly low penetrance *CFAP46* variants with high allele frequencies, there is still Limited evidence supporting a gene-disease relationship between variants in *CFAP46* and *CFAP46*-Related Primary Ciliary Dyskinesia. This classification was approved by the ClinGen Motile Ciliopathy GCEP on July 10, 2025 (SOP Version 11). \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0bb70629-5021-43d7-bf4b-8988e33bad44","GCISnapshot":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2025-10-16T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2025-10-17T23:53:35.777Z","role":"Publisher"}],"curationReasonDescription":"The Motile Ciliopathy GCEP has modified the CFAP46/ PCD gene disease association to a Limited classification because of concerns with the high allele frequency (gnomAD v4.1.0) of both CFAP46 variants associated with the single published PCD proband (PMID: 39362668). The GCEP acknowledges that the authors have provided evidence of loss of CFAP46 protein and diminished ciliary function in this proband but would like a better understanding of the conditions/mechanism that have led to the pathogenicity of these variants in this particular proband when there appears to be low penetrance of these variants in presumably healthy individuals (see gnomAD v4.1.0).  \n","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d4450ce-9f54-4713-b1f6-54ab00fa18c4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c4fadff-d58c-40f8-b5af-0d758189e594","type":"EvidenceLine","dc:description":"NM_001200049.3(CFAP46):c.19C>T (p.Gln7Ter) is a nonsense mutation predicted to either trigger nonsense-mediated decay or produce a severely truncated protein (CFAP46 is a 2715 aa protein). Down-scored by 1 point due to high allele frequency in gnomAD (This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.0045, with 4738 alleles/1041864 total alleles in the European (non-Finnish) population).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c4fadff-d58c-40f8-b5af-0d758189e594_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39362668","allele":{"id":"https://genegraph.clinicalgenome.org/r/a24d21df-c138-4d93-b388-4f7b7a88efb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001200049.3(CFAP46):c.19C>T (p.Gln7Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5758471"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/36ca8cf9-c217-496c-8d71-1c96399adc3c","type":"EvidenceLine","dc:description":"Down-scored by 1 point due to high allele frequency in gnomAD (This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.0029, with 3544 alleles/1176588 total alleles in the European (non-Finnish) population).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36ca8cf9-c217-496c-8d71-1c96399adc3c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"cDNA sequencing revealed that NM_001200049.3(CFAP46):c.7286-2A>G leads to activation of a cryptic splice site, causing a frameshift and premature stop of translation (p.Glu2429Gly_Met2430insfsTer9), resulting in a truncation of CFAP46. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/36ca8cf9-c217-496c-8d71-1c96399adc3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39362668","allele":{"id":"https://genegraph.clinicalgenome.org/r/a44e8a72-55e8-4489-8b4a-cbd2e66db15b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001200049.3(CFAP46):c.7286-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5756554"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5d4450ce-9f54-4713-b1f6-54ab00fa18c4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39362668","rdfs:label":"OP-64 II2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a44e8a72-55e8-4489-8b4a-cbd2e66db15b"},{"id":"https://genegraph.clinicalgenome.org/r/a24d21df-c138-4d93-b388-4f7b7a88efb2"}],"detectionMethod":"High-throughput sequencing was performed including whole exome sequencing, whole genome sequencing and a customised PCD gene panel  comprising the genes CFAP46, CFAP54, CFAP74, CFAP221, CFAP99 and CFAP297.\nNext-generation sequencing used to investigate a large cohort of 920 PCD-suspected individuals for variants in known PCD genes (CFAP74, CFAP221) and candidate genes (CFAP46, CFAP54, CFAP99, CFAP297), all encoding C1d components. The main inclusion criteria for this cohort were recurrent airway infections and the presence of situs solitus. No disease-causing variants in previously known PCD genes","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"chronic respiratory disease, normal nNO (235.6 nL/min), normal TEM, normal HSVM, situs solitus. Spermiogram of OP-64 II2 (CFAP46) showed normal results, which does not completely rule out subtle swimming deficits ","phenotypes":["obo:HP_0002110","obo:HP_0000388","obo:HP_0002257","obo:HP_0011109","obo:HP_0100582","obo:HP_0000365","obo:HP_0025695"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/36ca8cf9-c217-496c-8d71-1c96399adc3c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2c4fadff-d58c-40f8-b5af-0d758189e594_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8d83791-1e5f-43f1-a93c-edc039b5f628","type":"EvidenceLine","dc:description":"Down-scored because as a model, Chlamydomonas is unable to fully recapitulate human ciliary and respiratory phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5082c276-1eaa-4463-842b-d3d10e1b44aa","type":"Finding","dc:description":"Chlamydomonas fap46-1 cells show signs of flagellar dysfunction.  In the case of Chlamydomonas, the resulting phenotype is no motility or slow swimming with altered flagellar motility.  A human CFAP46 patient has respiratory phenotypes, suggesting dysfunction of respiratory cilia.  In both cases the axoneme (ciliary or flagellar) seems to be defective.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22573824","rdfs:label":"Chlamydomonas FAP46 mutant with impaired motility","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/29b3a151-231c-4c4e-b6a1-07d3c6b6d14b","type":"EvidenceLine","dc:description":"Down-scored because as a model, Chlamydomonas is unable to fully recapitulate human ciliary and respiratory phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89c710ff-a221-43ce-91f8-5de2a6f75577","type":"Finding","dc:description":"Motility was completely rescued in the fap46-1::FAP46 strain. Flagellar beat frequency was completely restored ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22573824","rdfs:label":"Chlamydomonas FAP46 rescue experiment","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de1e8f6a-ed9c-441b-b6ca-1a2ee9b1fb85","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6728fcd6-5852-4696-8f15-c53f7c0963b6","type":"FunctionalAlteration","dc:description":"Authors used in vitro ciliary transport assays analysing the ciliary transport of fluorescent nanoparticles on ALI-cultured respiratory epithelium from PCD patients and healthy controls. In vitro ciliary transport is impaired in CFAP46-variant individuals OP-64 II2, (37.6%reduction). (Ciliary beat frequency was not altered compared to controls)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39362668","rdfs:label":"In vitro ciliary transport assays"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/58e70f8b-5717-45bd-b040-1d4b25d27c63","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c41d9f2-902c-4275-8f3d-0f8937e13039","type":"FunctionalAlteration","dc:description":"Immunofluorescent analysis (using CFAP46 antibody) of respiratory cells shows that CFAP46 is undetectable in respiratory cilia from the CFAP46-variant individual OP-64 II2, suggesting a disruption of the C1d central pair projection.  Protein is missing or truncated on Western blot analysis.  In healthy cells, CFAP46 localizes along the entire ciliary axoneme.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39362668","rdfs:label":"IF studies of respiratory cilia from the CFAP46 patient"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/eabe809a-1203-4d42-9052-21f39717754f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7a54d4a-61ef-4d24-b1f8-07fb06826ed7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9afc7d4-04cf-40ae-ad73-84ea57228867","type":"Finding","dc:description":"Chlamydomonas fap46-1 cells show signs of flagellar dysfunction.   A human CFAP46 patient has respiratory phenotypes, suggesting dysfunction of respiratory cilia.  In both cases the axoneme (ciliary or flagellar) seems to be defective.  The FAP46 Chlamydomonas mutant suggests that the ciliary dysfunction seen in CFAP46 PCD could be from an alteration in microtubule sliding.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22573824","rdfs:label":"In vitro microtubule-sliding assays","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54803cee-74a8-495b-a81b-132d2fa1b338","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdd5dd1d-0e03-4a6c-bad7-6385fca675aa","type":"Finding","dc:description":"C. reinhardtii central pair proteins FAP54, FAP46, FAP74, and FAP221 co-immunoprecipitate with calmodulin (using calmodulin antibody)and form a single complex (proteins in complex identified by SDS-page electrophoresis followed by mass spectrometry peptide analysis and comparison to  C. reinhardtii genome). These proteins form the C1d projection of the central pair apparatus. Anti-FAP74 antibodies also precipitated all four members of the complex from WT axonemal extracts.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20421426","rdfs:label":"Coimmunoprecipitation of C1d projection subunits","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ce8783bf-d21f-4fce-9f20-f267d4286ca7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69cca73b-6f97-4cd3-add2-4f04e052e429","type":"Finding","dc:description":"CFAP54 and CFAP46 are part of the C1d projection complex of the central pair apparatus.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35578022","rdfs:label":"Cryo-EM structure of central pair apparatus (atomic model)","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81f17f1b-bde0-4eae-addf-fa5089b7a956","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64f279f7-bfb6-4aaf-bc8b-e6989c982820","type":"Finding","dc:description":"The Genotype-Tissue Expression (GTEx) project has established a resource database and associated tissue bank for the scientific community to study the relationship between genetic variation and gene expression in human tissues. RNA-seq expression studies were performed on 54 reference tissues. Bulk tissue gene expression for CFAP46 shows the expression of CFAP46 in lung, testis, brain, and Fallopian tube. This pattern is consistent with the presence of the C1d projection complex (of which CFAP46 is a component) in the axonemes of motile cilia and sperm flagella.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"GTEx CFAP46 gene expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Limited","sequence":12053,"specifiedBy":"GeneValidityCriteria11","strengthScore":7.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/vR9AqW7GC2I","type":"GeneValidityProposition","disease":"obo:MONDO_1010146","gene":"hgnc:25247","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_eabe809a-1203-4d42-9052-21f39717754f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}